Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John D. Mayfield
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
Cancer Cell
Cancer Research
Oncology
Cell Biology
Related publications
Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer
Journal of Clinical Investigation
Medicine
Heat-Shock Protein 27 (HSP27, HSPB1) Is Synthetic Lethal to Cells With Oncogenic Activation of MET, EGFR and BRAF
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches
Trends in Cancer
Cancer Research
Oncology
Actionable Activating Oncogenic ERRB2/HER2 Transmembrane and Juxtamembrane Domain Mutations
Cancer Cell
Cancer Research
Oncology
Cell Biology
Allosteric Activation of PI3Kα By Oncogenic Mutations
Oncotarget
Oncology
EGFR Activation Constitutes an Adaptive Response to BRAF Inhibitor Therapy
Cancer Discovery
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Unresponsiveness of Colon Cancer to BRAF(V600E) Inhibition Through Feedback Activation of EGFR
Nature
Multidisciplinary
Detection of EGFR- And HER2-activating Mutations in Squamous Cell Carcinoma Involving the Head and Neck
Modern Pathology
Forensic Medicine
Pathology